1. Home
  2. UBX vs JDZG Comparison

UBX vs JDZG Comparison

Compare UBX & JDZG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UBX
  • JDZG
  • Stock Information
  • Founded
  • UBX 2009
  • JDZG 2020
  • Country
  • UBX United States
  • JDZG China
  • Employees
  • UBX N/A
  • JDZG N/A
  • Industry
  • UBX Biotechnology: Pharmaceutical Preparations
  • JDZG Other Consumer Services
  • Sector
  • UBX Health Care
  • JDZG Real Estate
  • Exchange
  • UBX Nasdaq
  • JDZG Nasdaq
  • Market Cap
  • UBX 18.4M
  • JDZG 18.4M
  • IPO Year
  • UBX 2018
  • JDZG 2024
  • Fundamental
  • Price
  • UBX $0.75
  • JDZG $0.62
  • Analyst Decision
  • UBX Strong Buy
  • JDZG
  • Analyst Count
  • UBX 3
  • JDZG 0
  • Target Price
  • UBX $5.33
  • JDZG N/A
  • AVG Volume (30 Days)
  • UBX 141.5K
  • JDZG 530.5K
  • Earning Date
  • UBX 04-22-2025
  • JDZG 05-27-2025
  • Dividend Yield
  • UBX N/A
  • JDZG N/A
  • EPS Growth
  • UBX N/A
  • JDZG N/A
  • EPS
  • UBX N/A
  • JDZG 0.03
  • Revenue
  • UBX N/A
  • JDZG $2,567,741.00
  • Revenue This Year
  • UBX N/A
  • JDZG N/A
  • Revenue Next Year
  • UBX N/A
  • JDZG N/A
  • P/E Ratio
  • UBX N/A
  • JDZG $17.32
  • Revenue Growth
  • UBX N/A
  • JDZG 20.36
  • 52 Week Low
  • UBX $0.85
  • JDZG $0.45
  • 52 Week High
  • UBX $3.10
  • JDZG $15.08
  • Technical
  • Relative Strength Index (RSI)
  • UBX 28.49
  • JDZG N/A
  • Support Level
  • UBX $0.70
  • JDZG N/A
  • Resistance Level
  • UBX $0.95
  • JDZG N/A
  • Average True Range (ATR)
  • UBX 0.10
  • JDZG 0.00
  • MACD
  • UBX -0.01
  • JDZG 0.00
  • Stochastic Oscillator
  • UBX 8.49
  • JDZG 0.00

About UBX Unity Biotechnology Inc.

Unity Biotechnology Inc designs therapeutics that prevent, halt, and reverse various diseases of aging. The company focuses on clearing senescent cells, and creating senolytic medicines. Its medicines target vulnerabilities to senescent cells to clear those cells from the human body while leaving normal cells unaffected. The firm focuses on age-associated diseases such as osteoarthritis, eye diseases, and pulmonary diseases. Its drug candidates include, UBX1325 is being developed for age-related diseases of the eye, including diabetic macular edema, or DME, UBX2089, which is a circulating hormone which is produced in the kidneys and choroid plexus of the brain, which is being researched for multiple neurology indications, and UBX2050.

About JDZG JIADE LIMITED Common stock

Jiade Ltd Ltd is engaged in providing one-stop comprehensive education supporting services to adult education institutions, through a wide range of software platforms and auxiliary solutions. The Group offers pre-enrollment guidance on school/selection and application development, training for entrance exams, and assistance in the application process. The Group also offers offline tutoring, exam administration services, guidance on graduation thesis, and social practice assistance in the People's Republic of China.

Share on Social Networks: